The chemotherapy of chagas' disease: an overview.

  • Paulino M
  • Iribarne F
  • Dubin M
 et al. 
  • 13


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


The review presents: a) a brief description of the disease; b) a summary of the most important metabolic targets so far identified in Trypanosome cruzi (T. cruzi) along with corresponding inhibitor compounds; c) the current state of knowledge on the trypanothione reductase system of trypanosomatids with reference to oxidative stress defenses; d) detailed discussions on T. cruzi trypanothione reductase inhibitors such as nitrofuranes, naphthoquinones and phenothiazines. As yet, the chemotherapy of Chagas' disease remains an unsolved problem. Further search for new drugs must continue by means of nucleating existing chemotherapy efforts.

Author-supplied keywords

  • antichagasic agents
  • chemotherapy targets
  • trypanosomiasis
  • trypanothione metabolism
  • trypanothione reductase

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • M Paulino

  • F Iribarne

  • M Dubin

  • S Aguilera-Morales

  • O Tapia

  • a O M Stoppani

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free